Our data show that high EZH2 transcript levels were related to high-grade, BRCA1-mutated ovarian cancers, which in turn were very strongly associated with cell cycle promoting factors E2F1 and E2F3a. All this indicates that EZH2 high expressing cancers exhibit a very high proliferative turnover. The gene discussed is E2F1; the disease is ovarian carcinoma.